Second Sight Medical Products Inc (EYES)

[zitry]

Maybe the price will revisit. Support is somewhere around $1.69. However, if, the big "if", the ORION patient study results are as positive as I believe they will be the price will never again retreat to current support. When will the results from the ORION patient control group be released? I have no idea! It also could turn out negative! If it did, you will be 100% correct. Unlike ARGUS, ORION requires invasive surgery and with that, as we all know, complications may result.
Although we have met one technical milestone, the 20 day moving average above the 100 day MA; EYES 50 day MA is still well below the 200 day MA. Because of the continued insider buying, I believe the ORION patient studies are promising. ORION opens up a new huge well defined market. When a market is this well defined and EYES is the clear worldwide leader; this stock has the potential for exponential returns. With potential exponential returns corresponding risk is always present. If ORION results are mixed or ORION fails I believe it will be a long time before we see a breakout and most likely EYES will retrace and it is back to the drawing board for Second Sight. The converse will result in exponential returns. It is a tough decision. My portfolio is substantially over-weighted with EYES. Because of this, human nature drives a bullish bias, conscious or not! Always take that into account as related to my occasional posts.